Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Riassunto 
Robert M. Hershberg founded VentiRx Pharmaceuticals, Inc. Presently, Dr. Hershberg is Chairman, President & Chief Executive Officer at HilleVax, Inc.

He is also Member of UW Medicine and on the board of 5 other companies.

In the past he held the position of President, Chief Executive Officer & Director at VentiRx Pharmaceuticals, Inc., Chief Scientific Officer & Executive VP at Celgene Corp., Chief Medical Officer & Senior Vice President for Dendreon Corp., Vice President-Medical Genetics at Corixa Corp. and Assistant Professor at Harvard Medical School.

Robert M. Hershberg received a doctorate and an undergraduate degree from the University of California, Los Angeles and a doctorate from The Salk Institute for Biological Studies.


Posti e reponsabilitÓ di Robert M. Hershberg 
NomeTitolo Da
Fate Therapeutics, Inc.
(Biotecnologia)
Independent Director 2020
Adaptive Biotechnologies Corporation
(Biotecnologia)
Independent Director 2013
Recursion Pharmaceuticals, Inc.
(Biotecnologia)
Independent Director 2020
NanoString Technologies, Inc.
(Fornitura medica)
Independent Director 2015
Silverback Therapeutics, Inc.
(Biotecnologia)
Independent Director 2016
HilleVax, Inc. Chairman, President & Chief Executive Officer -
UW Medicine Member -


Participazioni di Robert M. Hershberg 
NomeAzioni%Valorizzazione
NanoString Technologies, Inc. (NSTG)
(Fornitura medica)
7 4100,016%431 262 USD
Fate Therapeutics, Inc. (FATE)
(Biotecnologia)
2 6810,0028%196 383 USD
Recursion Pharmaceuticals, Inc. (RXRX)
(Biotecnologia)
6 5970,0041%166 376 USD
Adaptive Biotechnologies Corporation (ADPT)
(Biotecnologia)
00,0000%0 USD
Silverback Therapeutics, Inc. (SBTX)
(Biotecnologia)
00,0000%0 USD


Robert M. Hershberg: network personale 
Le notizie pi¨ lette 
15/09BRAD SMITH: Microsoft annuncia il riacquisto di azioni fino a 60 miliardi di dollari e aumenta il dividendo
MR
13/09MARTIN SORRELL: S4 Capital di Sorrell alza le prospettive di profitto al 40%
MR
14/09STEPHEN SCHERR: Goldman Sachs nomina Coleman come nuovo CFO, sostituendo Scherr
MR
08/09MICHAEL O'LEARY: Ryanair, aeroporti britannici in difficoltà a Natale - O'Leary
RE
09/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone arrotonda quota a 6,1%
RE
17/09LEONARDO DEL VECCHIO: Generali, Caltagirone e Del Vecchio cercano alleati, non vogliono Opa
RE
15/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone aumenta quota di ulteriore 0,11%, sale sopra 6%
RE
14/09VINCENT BOLLORÉ: Bolloré avrà quota Universal da 5,9 mld euro dopo quotazione
RE
Pi¨ notizie


© 2021 People and Ownership :   
Robert M. Hershberg : connessioni